1. Home
  2. FEMY vs JSPR Comparison

FEMY vs JSPR Comparison

Compare FEMY & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Femasys Inc.

FEMY

Femasys Inc.

HOLD

Current Price

$0.82

Market Cap

51.5M

Sector

Health Care

ML Signal

HOLD

Logo Jasper Therapeutics Inc.

JSPR

Jasper Therapeutics Inc.

HOLD

Current Price

$1.85

Market Cap

48.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FEMY
JSPR
Founded
2004
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
51.5M
48.1M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
FEMY
JSPR
Price
$0.82
$1.85
Analyst Decision
Strong Buy
Buy
Analyst Count
3
11
Target Price
$6.83
$21.44
AVG Volume (30 Days)
1.4M
3.9M
Earning Date
11-14-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,061,502.00
N/A
Revenue This Year
$64.02
N/A
Revenue Next Year
$147.19
N/A
P/E Ratio
N/A
N/A
Revenue Growth
63.53
N/A
52 Week Low
$0.31
$1.39
52 Week High
$1.80
$22.99

Technical Indicators

Market Signals
Indicator
FEMY
JSPR
Relative Strength Index (RSI) 47.72 50.72
Support Level $0.79 $1.61
Resistance Level $0.89 $1.96
Average True Range (ATR) 0.07 0.14
MACD -0.01 0.03
Stochastic Oscillator 26.39 67.57

Price Performance

Historical Comparison
FEMY
JSPR

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

About JSPR Jasper Therapeutics Inc.

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.

Share on Social Networks: